Emmanuel Heilmann

493 total citations · 1 hit paper
11 papers, 237 citations indexed

About

Emmanuel Heilmann is a scholar working on Infectious Diseases, Epidemiology and Genetics. According to data from OpenAlex, Emmanuel Heilmann has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Emmanuel Heilmann's work include SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (5 papers) and Virology and Viral Diseases (4 papers). Emmanuel Heilmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (5 papers) and Virology and Viral Diseases (4 papers). Emmanuel Heilmann collaborates with scholars based in Austria, United States and Saudi Arabia. Emmanuel Heilmann's co-authors include Dorotheé von Laer, Francesco Costacurta, Reuben S. Harris, Seyed Arad Moghadasi, Chengjin Ye, Luis Martínez‐Sobrido, André Volland, Bernhard Rupp, Ahmed Magdy Khalil and Hideki Aihara and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Science Advances.

In The Last Decade

Emmanuel Heilmann

11 papers receiving 236 citations

Hit Papers

Transmissible SARS-CoV-2 variants with resistance to clin... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Heilmann Austria 8 168 84 77 29 25 11 237
Maria I. Luck United States 3 230 1.4× 101 1.2× 89 1.2× 25 0.9× 13 0.5× 4 300
André Volland Austria 8 191 1.1× 38 0.5× 61 0.8× 30 1.0× 25 1.0× 10 277
Seyed Arad Moghadasi United States 8 219 1.3× 94 1.1× 117 1.5× 39 1.3× 18 0.7× 16 329
Md. Jahirul Islam Bangladesh 9 110 0.7× 52 0.6× 148 1.9× 29 1.0× 22 0.9× 20 291
Adrien Delpal France 6 141 0.8× 44 0.5× 74 1.0× 28 1.0× 12 0.5× 11 216
Francesco Costacurta Austria 5 153 0.9× 81 1.0× 62 0.8× 18 0.6× 8 0.3× 8 198
Line A. Ryberg Denmark 7 179 1.1× 67 0.8× 106 1.4× 19 0.7× 8 0.3× 10 287
Zhi-Lin Ren China 5 263 1.6× 144 1.7× 134 1.7× 18 0.6× 15 0.6× 8 371
Dan Cao China 6 179 1.1× 112 1.3× 124 1.6× 28 1.0× 16 0.6× 12 323
Lian Jacobs United States 4 148 0.9× 72 0.9× 69 0.9× 12 0.4× 13 0.5× 6 217

Countries citing papers authored by Emmanuel Heilmann

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Heilmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Heilmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Heilmann more than expected).

Fields of papers citing papers by Emmanuel Heilmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Heilmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Heilmann. The network helps show where Emmanuel Heilmann may publish in the future.

Co-authorship network of co-authors of Emmanuel Heilmann

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Heilmann. A scholar is included among the top collaborators of Emmanuel Heilmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Heilmann. Emmanuel Heilmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Costacurta, Francesco, et al.. (2024). Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution. Current Protocols. 4(12). e70074–e70074. 1 indexed citations
2.
Bante, David, Andreas Naschberger, Francesco Costacurta, et al.. (2024). Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir. SHILAP Revista de lepidopterología. 2(1). 23–23. 9 indexed citations
3.
Costacurta, Francesco, David Bante, Xi He, et al.. (2024). Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system. Antiviral Research. 231. 105969–105969. 7 indexed citations
4.
Costacurta, Francesco, et al.. (2024). Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements. Current Protocols. 4(11). e70062–e70062. 1 indexed citations
5.
Bante, David, Francesco Costacurta, Seyed Arad Moghadasi, et al.. (2024). Highly Specific Sars-Cov-2 Main Protease (Mpro) Mutations Against the Clinical Antiviral Ensitrelvir Selected in a Safe, Vsv-Based System. SSRN Electronic Journal. 1 indexed citations
6.
Moghadasi, Seyed Arad, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.. (2023). Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Science Advances. 9(13). eade8778–eade8778. 94 indexed citations breakdown →
7.
Heilmann, Emmanuel, Francesco Costacurta, Seyed Arad Moghadasi, et al.. (2022). SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Science Translational Medicine. 15(678). eabq7360–eabq7360. 69 indexed citations
8.
Heilmann, Emmanuel, Francesco Costacurta, Stephan Geley, et al.. (2022). A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition. Communications Biology. 5(1). 391–391. 16 indexed citations
9.
Heilmann, Emmanuel, Janine Kimpel, Benedikt Hofer, et al.. (2021). Chemogenetic ON and OFF switches for RNA virus replication. Nature Communications. 12(1). 1362–1362. 7 indexed citations
10.
Volland, André, et al.. (2021). Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. PLoS Pathogens. 17(10). e1009996–e1009996. 21 indexed citations
11.
Heilmann, Emmanuel, Janine Kimpel, Stephan Geley, et al.. (2019). The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion. Viruses. 11(11). 989–989. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026